Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M H Harirchian

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Multiple Sclerosis (Houndmills, Basingstoke, England)|January 23, 2013
Imatinib-induced amelioration of neurologic deficits in a rare case of simultaneous association of missed multiple sclerosis and chronic myeloblastic leukemiaB Siroos, M H Harirchian, R Abolfazli
Multiple Sclerosis and Related Disorders|September 9, 2015
Emerging tumefactive MS after switching therapy from interferon-beta to fingolimod: A case reportM H Harirchian, A Taalimi, B Siroos
Indian Journal of Pathology & Microbiology|May 31, 2011
Lafora disease: a case report, pathologic and genetic studyM H Harirchian, E Esmailee Shandiz, J Turnbull, et al.
Neurophysiologie Clinique = Clinical Neurophysiology|November 15, 2011
Sympathetic skin response (SSR) in multiple sclerosis and clinically isolated syndrome: a case-control studyV Aghamollaii, M H Harirchian, A Modabbernia, et al.
Dementia and Geriatric Cognitive Disorders Extra|December 14, 2011
Pharmacogenetic Study on the Effect of Rivastigmine on PS2 and APOE Genes in Iranian Alzheimer PatientsM Zamani, M Mehri, A Kollaee, et al.
Australasian Physical & Engineering Sciences in Medicine|November 4, 2015
Quantification of diagnostic biomarkers to detect multiple sclerosis lesions employing (1)H-MRSI at 3TH Vafaeyan, S A Ebrahimzadeh, N Rahimian, et al.
European Journal of Neurology|July 21, 2011
Serum and CSF PDGF-AA and FGF-2 in relapsing-remitting multiple sclerosis: a case-control studyM H Harirchian, A H Tekieh, A Modabbernia, et al.
Journal of Clinical Pharmacy and Therapeutics|September 14, 2010
Saffron in the treatment of patients with mild to moderate Alzheimer's disease: a 16-week, randomized and placebo-controlled trialS Akhondzadeh, M Shafiee Sabet, M H Harirchian, et al.
AJNR. American Journal of Neuroradiology|December 27, 2022
Does Gadolinium Deposition Lead to Metabolite Alteration in the Dentate Nucleus? An MRS Study in Patients with MSM Mohammadzadeh, S Kolahi, M-M Mehrabi Nejad, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Multiple Sclerosis (Houndmills, Basingstoke, England)|January 23, 2013
Imatinib-induced amelioration of neurologic deficits in a rare case of simultaneous association of missed multiple sclerosis and chronic myeloblastic leukemiaB Siroos, M H Harirchian, R Abolfazli
Multiple Sclerosis and Related Disorders|September 9, 2015
Emerging tumefactive MS after switching therapy from interferon-beta to fingolimod: A case reportM H Harirchian, A Taalimi, B Siroos
Indian Journal of Pathology & Microbiology|May 31, 2011
Lafora disease: a case report, pathologic and genetic studyM H Harirchian, E Esmailee Shandiz, J Turnbull, et al.
Neurophysiologie Clinique = Clinical Neurophysiology|November 15, 2011
Sympathetic skin response (SSR) in multiple sclerosis and clinically isolated syndrome: a case-control studyV Aghamollaii, M H Harirchian, A Modabbernia, et al.
Dementia and Geriatric Cognitive Disorders Extra|December 14, 2011
Pharmacogenetic Study on the Effect of Rivastigmine on PS2 and APOE Genes in Iranian Alzheimer PatientsM Zamani, M Mehri, A Kollaee, et al.
Australasian Physical & Engineering Sciences in Medicine|November 4, 2015
Quantification of diagnostic biomarkers to detect multiple sclerosis lesions employing (1)H-MRSI at 3TH Vafaeyan, S A Ebrahimzadeh, N Rahimian, et al.
European Journal of Neurology|July 21, 2011
Serum and CSF PDGF-AA and FGF-2 in relapsing-remitting multiple sclerosis: a case-control studyM H Harirchian, A H Tekieh, A Modabbernia, et al.
Journal of Clinical Pharmacy and Therapeutics|September 14, 2010
Saffron in the treatment of patients with mild to moderate Alzheimer's disease: a 16-week, randomized and placebo-controlled trialS Akhondzadeh, M Shafiee Sabet, M H Harirchian, et al.
AJNR. American Journal of Neuroradiology|December 27, 2022
Does Gadolinium Deposition Lead to Metabolite Alteration in the Dentate Nucleus? An MRS Study in Patients with MSM Mohammadzadeh, S Kolahi, M-M Mehrabi Nejad, et al.
Pageof 1